Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management
R Ruggiero, R Di Napoli, N Balzano… - Expert Review of …, 2023 - Taylor & Francis
ABSTRACT Introduction Immune checkpoint inhibitors (ICIs) represent an innovative
therapeutic approach of oncologic diseases. In Europe, this therapeutic class currently …
therapeutic approach of oncologic diseases. In Europe, this therapeutic class currently …
Neurological adverse events of immune checkpoint inhibitors: an update of clinical presentations, diagnosis, and management
A Farina, M Villagrán-García, J Honnorat - Revue Neurologique, 2023 - Elsevier
The use of immune checkpoint inhibitors (ICIs) has represented a major advance in cancer
treatment. By enhancing endogenous immune responses to destroy cancer cells, ICIs can …
treatment. By enhancing endogenous immune responses to destroy cancer cells, ICIs can …
CNS and PNS manifestation in immune checkpoint inhibitors: a systematic review
E Khan, AK Shrestha, M Elkhooly, H Wilson… - Journal of the …, 2022 - Elsevier
Introduction Immunomodulatory therapies, including the use of immune checkpoint inhibitors
(ICIs), have made a profound impact on treatment of advanced cancers in recent decades …
(ICIs), have made a profound impact on treatment of advanced cancers in recent decades …
Neurological Adverse Events Related to Immune Checkpoint Inhibitors: A Practical Review
F Zammit, E Seront - Pharmaceuticals, 2024 - mdpi.com
The increasing use of immune checkpoint inhibitors (ICI) in cancer therapy has brought
attention to their associated neurotoxicities, termed neurological immune-related adverse …
attention to their associated neurotoxicities, termed neurological immune-related adverse …
Neurologic manifestations of autoimmunity with immune checkpoint inhibitors
JA McCombe, E Sechi, A Zekeridou - Handbook of Clinical Neurology, 2024 - Elsevier
Immune checkpoint inhibitors (ICIs) are cancer immunotherapies that enhance the body's
own immune system to treat cancer. ICI treatment, however, can cause immune-related …
own immune system to treat cancer. ICI treatment, however, can cause immune-related …
Predictors for the development of neurological immune‐related adverse events of immune checkpoint inhibitors and impact on mortality
C Yan, M Huang, C Swetlik, K Toljan… - European Journal of …, 2023 - Wiley Online Library
Background and purpose Little is known about risk factors for developing neurological
immunological adverse events (neuro‐irAEs) from immune checkpoint inhibitors (ICIs). We …
immunological adverse events (neuro‐irAEs) from immune checkpoint inhibitors (ICIs). We …
How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update
A Vogrig, S Muñiz-Castrillo, A Farina, J Honnorat… - Journal of …, 2022 - Springer
As the use of cancer immunotherapy with immune checkpoint inhibitors (ICIs) is expanding
rapidly for the treatment of many tumor types, it is crucial that both neurologists and …
rapidly for the treatment of many tumor types, it is crucial that both neurologists and …
Severe neurologic complications of immune checkpoint inhibitors: a single-center review
S Mancone, T Lycan, T Ahmed, U Topaloglu… - Journal of …, 2018 - Springer
Abstract Background Immune checkpoint inhibitors (ICIs) are a promising class of anticancer
drugs associated with immune-related adverse events (IRAEs). In registration studies of …
drugs associated with immune-related adverse events (IRAEs). In registration studies of …
Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice
M Villagrán-García, R Velasco - Neurological Sciences, 2022 - Springer
Neurological, immune-related adverse events (n-irAE) due to immune checkpoint inhibitors
(ICI) represent a growing clinical problem in neuro-oncology practice. Although rare, the …
(ICI) represent a growing clinical problem in neuro-oncology practice. Although rare, the …
Neurologic immune-related adverse events associated with immune checkpoint inhibition
PC Pan, A Haggiagi - Current Oncology Reports, 2019 - Springer
Abstract Purpose of Review This review highlights the spectrum of neurologic adverse
events seen with use of immune checkpoint inhibitors (ICIs), their potential mechanisms, the …
events seen with use of immune checkpoint inhibitors (ICIs), their potential mechanisms, the …
相关搜索
- checkpoint inhibitors adverse events
- checkpoint inhibitors focus on neurotoxicity
- clinical management focus on neurotoxicity
- adverse events focus on neurotoxicity
- checkpoint inhibitors clinical management
- clinical management adverse events
- checkpoint inhibitors neuro oncology
- checkpoint inhibitors neurological toxicities
- immune checkpoint inhibitors growing issue
- faers database checkpoint inhibitor
- checkpoint inhibitors predictors for the development
- checkpoint inhibitors impact on mortality
- adverse events predictors for the development
- adverse events impact on mortality
- checkpoint inhibitors clinical presentations
- checkpoint inhibitors neurologic manifestations